Skip to main content
Premium Trial:

Request an Annual Quote

Mark Wingerd, David Goodlett, Eugene Davidov, Paul Fletcher

Premium

Mark Wingerd has become director of the proteomics facility at the Institute of Systems Biology, the ISB said last week. He succeeds David Goodlett, who left for a faculty position at the University of Washington. Wingerd joins the institute from Pacific Northwest National Laboratory, where he helped establish a proteomics facility.


Eugene Davidov has been appointed as director of the Yale Center for Genomics and Proteomics, and Paul Fletcher as director of the center’s chemical genomics and screening facility. Before coming to Yale, Davidov was a principal investigator at Beyond Genomics. Prior to that, he worked at Millennium Pharmaceuticals and Anadys Pharmaceuticals. Davidov holds a PhD in biochemistry from Clark University. Fletcher joins Yale from Edison, NJ-based DGI BioTechnologies. He holds a PhD in reproductive physiology and biochemistry from the University of Wyoming.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.